• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Cardionet

Anonymous board for Cardionet
Replies
10
Views
5K
anonymous
Replies
0
Views
242
anonymous
Replies
10
Views
1K
anonymous
Replies
3
Views
2K
anonymous
Replies
20
Views
3K
anonymous
Replies
327
Views
57K
anonymous
Replies
11
Views
4K
anonymous
Replies
19
Views
3K
anonymous
Replies
27
Views
6K
anonymous
Replies
130
Views
35K
anonymous
Replies
0
Views
1K
anonymous
Replies
31
Views
9K
anonymous
Replies
7
Views
2K
anonymous
Replies
11
Views
3K
anonymous
Replies
35
Views
6K
anonymous
Replies
1
Views
2K
anonymous
Replies
7
Views
2K
anonymous
Replies
8
Views
2K
anonymous
Replies
9
Views
2K
anonymous